Product Development Partnerships
The research and development of more effective drugs, vaccines, diagnostics and other health tools for neglected diseases is hindered by large upfront costs and low market returns. Product Development Partnerships (PDPs), which bring together public, private, academic and philanthropic actors, have emerged over the last two decades to drive the development of new tools for use in poor-country settings where commercial incentives alone will not drive product development. Australian Aid has funded PDPs to develop new tools for tuberculosis and malaria since 2013. An independent evaluation in 2017 found the investments performed strongly and represented good value for money. Through the flagship $75 million PDP Fund (2018-22), the Health Security Initiative for the Indo-Pacific extends and expands DFAT’s support for PDPs. The Fund aims to strengthen the global response against drug-resistant tuberculosis and malaria, and other mosquito-borne diseases through the development and market introduction of new tools, with a focus on the Indo-Pacific.
Click on the titles to learn more about our Product Development Partnerships: